Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America

<abstract language="eng">In terms of economics, implementing generic drug policy is nothing other than consolidating (or even, creating) drug markets that set competitive prices, the result of which favors public access to essential drugs. This article approaches the topic of generic...

Full description

Bibliographic Details
Main Author: Federico Tobar
Format: Article
Language:English
Published: Pan American Health Organization 2008-01-01
Series:Revista Panamericana de Salud Pública
Subjects:
Online Access:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000100008
id doaj-57104b8d51dc40beb4d465b58a1833fe
record_format Article
spelling doaj-57104b8d51dc40beb4d465b58a1833fe2020-11-25T00:54:24ZengPan American Health OrganizationRevista Panamericana de Salud Pública1020-49891680-53482008-01-012315967Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin AmericaFederico Tobar<abstract language="eng">In terms of economics, implementing generic drug policy is nothing other than consolidating (or even, creating) drug markets that set competitive prices, the result of which favors public access to essential drugs. This article approaches the topic of generic drugs from the economic perspective by examining various regulatory models in order to evaluate and leverage generic drug policy implementation options as a mechanism for battling some of the markets’ specific weaknesses. The conclusion is that there is no single unequivocal method for promoting the use of generic drugs, and that the most favorable way to integrate markets may be through a broad combination of alternatives. These alternatives are grouped and analyzed according to the market issues or challenges that must be overcome. Several options are then identified based on the degree of market consolidation to be obtained.http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000100008formulación de políticasmedicamentos genéricossimilarAmérica Latinapolicy makingdrugsgenericLatin America
collection DOAJ
language English
format Article
sources DOAJ
author Federico Tobar
spellingShingle Federico Tobar
Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America
Revista Panamericana de Salud Pública
formulación de políticas
medicamentos genéricos
similar
América Latina
policy making
drugs
generic
Latin America
author_facet Federico Tobar
author_sort Federico Tobar
title Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America
title_short Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America
title_full Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America
title_fullStr Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America
title_full_unstemmed Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America
title_sort economía de los medicamentos genéricos en américa latina economy of generic drugs in latin america
publisher Pan American Health Organization
series Revista Panamericana de Salud Pública
issn 1020-4989
1680-5348
publishDate 2008-01-01
description <abstract language="eng">In terms of economics, implementing generic drug policy is nothing other than consolidating (or even, creating) drug markets that set competitive prices, the result of which favors public access to essential drugs. This article approaches the topic of generic drugs from the economic perspective by examining various regulatory models in order to evaluate and leverage generic drug policy implementation options as a mechanism for battling some of the markets’ specific weaknesses. The conclusion is that there is no single unequivocal method for promoting the use of generic drugs, and that the most favorable way to integrate markets may be through a broad combination of alternatives. These alternatives are grouped and analyzed according to the market issues or challenges that must be overcome. Several options are then identified based on the degree of market consolidation to be obtained.
topic formulación de políticas
medicamentos genéricos
similar
América Latina
policy making
drugs
generic
Latin America
url http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000100008
work_keys_str_mv AT federicotobar economiadelosmedicamentosgenericosenamericalatinaeconomyofgenericdrugsinlatinamerica
_version_ 1725234312097300480